More Kids Without Access to Asthma Inhalers

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical “authorized generic,” but some families reportedly had trouble getting this drug because their insurance either didn’t cover it or required higher out-of-pocket costs, researchers reported April 26 in the Journal of the American Medical Association. As a result, children were 6...